Leflutrozole (BGS649)
Male hypogonadotropic hypogonadism (HH) A novel once weekly oral aromatase inhibitor that has completed a Phase 2b study in obesity-associated male hypogonadotropic hypogonadism (HH). STATUS: Open-to-Partnership
Male hypogonadotropic hypogonadism (HH) A novel once weekly oral aromatase inhibitor that has completed a Phase 2b study in obesity-associated male hypogonadotropic hypogonadism (HH). STATUS: Open-to-Partnership